IPNIpsen S.A.
168.50EUR+3.63%Mkt Cap: 15.16B $P/E: 31.79

Ipsen S.A., a biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience in North America, Europe, and internationally. It engages in the development of Soma…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
vs Drug Manufacturers - Specialty & Generic
P/E
Pricier
P/B
Pricier
Div Yield
Higher
1M Perf
Lower
MRK
Merck KGaA
$69.40BUSDP/E 25.2
UTHR
United Therapeutics Corporation
$23.00BUSDP/E 20.0
VTRS
Viatris Inc.
$18.49BUSD
NBIX
Neurocrine Biosciences, Inc.
$16.95BUSDP/E 26.0
SOBI
Swedish Orphan Biovitrum AB (publ)
$15.35BUSDP/E 175.0
ELAN
Elanco Animal Health Incorporated
$12.29BUSD
KRK
Krka, d. d.
$8.30BUSDP/E 21.1
HIMS
Hims & Hers Health, Inc.
$8.02BUSD
LNTH
Lantheus Holdings, Inc.
$7.22BUSDP/E 26.5
LQDA
Liquidia Corporation
$7.09BUSDP/E 469.0
AMRX
Amneal Pharmaceuticals, Inc.
$5.52BUSDP/E 46.8
SFZN
Siegfried Holding AG
$3.54BUSDP/E 18.4
HIK
Hikma Pharmaceuticals PLC
$3.48BUSDP/E 11.1
ROVI
Laboratorios Farmaceuticos Rovi, S.A.
$3.22BUSDP/E 22.4
ALM
Almirall, S.A.
$2.66BUSDP/E 59.3
SUPN
Supernus Pharmaceuticals, Inc.
$2.70BUSD
DMP
Dermapharm Holding SE
$2.54BUSDP/E 17.6
BCRX
BioCryst Pharmaceuticals, Inc.
$2.54BUSD
PBH
Prestige Consumer Healthcare Inc.
$2.24BUSDP/E 12.1
FAGR
Fagron NV
$1.92BUSDP/E 19.4
AMLX
Amylyx Pharmaceuticals, Inc.
$2.00BUSD
PPGN
PolyPeptide Group AG
$1.77BUSD
ANIP
ANI Pharmaceuticals, Inc.
$1.88BUSDP/E 21.2
BHC
Bausch Health Companies Inc.
$1.90BUSD
FAE
Faes Farma, S.A.
$1.56BUSDP/E 18.4
HROW
Harrow, Inc.
$1.58BUSD
XERS
Xeris Biopharma Holdings, Inc.
$1.37BUSDP/E 113.1
PAHC
Phibro Animal Health Corporation
$1.27BUSDP/E 13.5
BIOG-B
BioGaia AB (publ)
$1.13BUSDP/E 35.6
COLL
Collegium Pharmaceutical, Inc.
$1.17BUSDP/E 17.6
ECILC
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.
$1.23BUSD
BIOA
BioAge Labs, Inc.
$1.09BUSD
CRON
Cronos Group Inc.
$1.07BUSDP/E Infinity
EVT
Evotec SE
$964.80MUSD
PCRX
Pacira BioSciences, Inc.
$998.26MUSDP/E 195.2
ETON
Eton Pharmaceuticals, Inc.
$991.60MUSD
PHN
Pharmanutra S.p.A.
$912.76MUSDP/E 39.9
VETO
Vetoquinol SA
$895.85MUSDP/E 14.4
AMPH
Amphastar Pharmaceuticals, Inc.
$889.80MUSDP/E 12.2
ESPR
Esperion Therapeutics, Inc.
$814.31MUSDP/E Infinity
IRWD
Ironwood Pharmaceuticals, Inc.
$693.02MUSDP/E 6.8
GUD
Knight Therapeutics Inc.
$704.28MUSDP/E 164.2
BOI
Boiron SA
$522.76MUSDP/E 14.7
AQST
Aquestive Therapeutics, Inc.
$521.87MUSD
AGY
Allergy Therapeutics plc
$488.71MUSD
EOLS
Evolus, Inc.
$457.03MUSD
WEED
Canopy Growth Corporation
$450.66MUSD
EBS
Emergent BioSolutions Inc.
$432.38MUSD
SCYX
SCYNEXIS, Inc.
$323.33MUSD
ATB
Antibiotice S.A.
$317.55MUSDP/E 43.3
ORGO
Organogenesis Holdings Inc.
$312.68MUSD
DEVA
Deva Holding A.S.
$342.71MUSD
AKBA
Akebia Therapeutics, Inc.
$305.81MUSD
TKNO
Alpha Teknova, Inc.
$304.53MUSD
LAVI
Lavipharm S.A.
$288.10MUSDP/E 51.7
CPH
Cipher Pharmaceuticals Inc.
$308.25MUSDP/E 9.9
BIO
Biofarm S.A.
$294.94MUSDP/E 15.2
CLN
Celon Pharma S.A.
$268.98MUSDP/E 9.7
ANCR
Animalcare Group plc
$250.67MUSDP/E 47.7
SIGA
SIGA Technologies, Inc.
$261.08MUSDP/E 13.0
RJF
Laboratorio Reig Jofre, S.A.
$239.98MUSDP/E 53.8
LFCR
Lifecore Biomedical, Inc.
$196.92MUSD
DERM
Journey Medical Corporation
$194.94MUSD
ANIK
Anika Therapeutics, Inc.
$194.66MUSD
XLY
Auxly Cannabis Group Inc.
$182.70MUSDP/E 8.8
ACB
Aurora Cannabis Inc.
$178.18MUSD
PHO
Photocure ASA
$147.49MUSDP/E 18.8
ASRT
Assertio Holdings Inc
$151.86MUSD
EAPI
Euroapi S.A.
$138.58MUSD
OGI
Organigram Global Inc.
$148.14MUSD
CRDL
Cardiol Therapeutics Inc.
$125.08MUSD
RX
BioSyent Inc.
$119.66MUSDP/E 18.6
HLS
HLS Therapeutics Inc.
$100.44MUSD
CPIX
Cumberland Pharmaceuticals Inc.
$97.09MUSD
VISTN
Vistin Pharma ASA
$85.39MUSDP/E 12.3
ORX
Orexo AB (publ)
$80.64MUSD
STX
Shield Therapeutics plc
$72.08MUSD
EQL
EQL Pharma AB
$66.94MUSDP/E 56.4
AB
AB Science S.A.
$67.12MUSD
NANEXA
Nanexa AB (publ)
$64.16MUSD
EAH
ECO Animal Health Group plc
$66.36MUSDP/E 22.8
ENZY
Enzymatica AB (publ)
$55.72MUSD
CTOR
Citius Oncology, Inc.
$60.45MUSD
CINPHA
Cinclus Pharma Holding AB (publ)
$48.97MUSD
TLPH
Talphera, Inc.
$53.46MUSD
DB
Decibel Cannabis Company Inc.
$50.41MUSD
MOB
Moberg Pharma AB (publ)
$42.17MUSD
BTAI
BioXcel Therapeutics, Inc.
$43.54MUSD
MLC
Malin Corporation plc
$35.03MUSDP/E Infinity
PXS
Provexis plc
$32.51MUSD
TRILC
Turk Ilac Ve Serum Sanayi Anonim Sirketi
$29.51MUSD
TXMD
TherapeuticsMD, Inc.
$25.58MUSDP/E 221.0
AYTU
Aytu BioPharma, Inc.
$23.08MUSD
ROMJ
Rubicon Organics Inc.
$23.13MUSD
RMTI
Rockwell Medical, Inc.
$21.73MUSD
LABS
MediPharm Labs Corp.
$21.66MUSD
KLAR
Klaria Pharma Holding AB (publ.)
$18.56MUSD
VM
Voyageur Pharmaceuticals Ltd.
$16.34MUSD
MEDIC
Medicon Hellas S.A.
$14.36MUSDP/E 17.5
APUS
Apimeds Pharmaceuticals US, Inc.
$13.58MUSD
BFRI
Biofrontera Inc.
$12.11MUSD
CABR
Caring Brands, Inc.
$11.27MUSD
AVCN
Avicanna Inc.
$11.45MUSD
MPH
Medicure Inc.
$9.80MUSD
PCLO
PharmaCielo Ltd.
$8.90MUSD
YCBD
cbdMD, Inc.
$7.07MUSDP/E 0.3
STENO
Stenocare A/S
$6.32MUSD
SNOA
Sonoma Pharmaceuticals, Inc.
$5.89MUSD
NUTEX
NUTEX Investments Public Limited Company
$4.95MUSDP/E 4.0
MUSH
Mercanto Holdings Inc.
$5.64MUSDP/E Infinity
EGRX
Eagle Pharmaceuticals, Inc.
$3.29MUSDP/E 1.4
GABA
Gabather AB (publ)
$2.15MUSD
ERMA
Enorama Pharma AB (publ)
$1.93MUSD
SHPH
Shuttle Pharmaceuticals Holdings, Inc.
$1.90MUSDP/E 32.5
CANB
CanadaBis Capital Inc.
$1.54MUSD
GENX
Genix Pharmaceuticals Corporation
$668.8KUSD
PTPI
Petros Pharmaceuticals, Inc.
$216.1KUSDP/E 0.0
CLVR
Clever Leaves Holdings Inc.
$350USD
Indicators:|

Key Statistics

Company
Market Cap15.16B $
Enterprise Value14.56B $
Revenue (TTM)4.27B $
Gross Profit3.45B $
Net Income (TTM)482.07M $
Revenue/Share51.67 USD
Last Price168.50 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees5.5K
CountryFR
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN
Valuation
P/E (Trailing)31.79
P/E (Forward)12.28
PEG0.97
EV/EBITDA9.99
EV/Revenue3.41
P/S3.55
P/B3.22
EPS (TTM)5.31
EPS (Forward)13.74
52W Range
101.2093% of range173.50
52W High173.50 EUR
52W Low101.20 EUR
Profitability
Gross Margin80.89%
Oper. Margin26.10%
EBITDA Margin34.11%
Profit Margin11.29%
ROE10.23%
ROA6.39%
Growth
Revenue Growth9.30%
Earnings Growth-3.90%
Cash Flow & Leverage
Operating CF1.24B $
CapEx (TTM)357.28M $
FCF Margin16.59%
FCF Yield4.67%
Net Debt-604.46M $
Net Debt/EBITDA-0.41
Balance Sheet
Debt/Equity0.20
Current Ratio1.96
Quick Ratio1.69
Book Value/Sh52.47 EUR
Cash/Share18.47 EUR
Dividends
Fwd Div Rate1.600 EUR
Trail. Div Rate1.400 EUR
Div. Yield0.97%
5Y Avg Yield1.12%
Payout Ratio26.32%
Ex-Div DateJun 3, 2026
Pay Date
Analyst Consensus
Rating2.4 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)160.00 EUR
Upside (mean)-5.0%
Target Range117.00 EUR215.00 EUR
117.00-5.0% to mean215.00
# Analysts15
Ownership
Shares Out.82.65M
Float30.11M
Insiders57.64%
Institutions21.00%
Technical
SMA 50160.72 (+4.8%)
SMA 200141.41 (+19.2%)
Beta0.32
S&P 52W Chg20.05%
Avg Vol (30d)81.53K
Avg Vol (10d)150.49K
Technical Indicators
RSI (14)65.5
MACD1.2742
MACD Signal-0.0864
MACD Hist.+1.3606
BB Upper166.30 EUR
BB Middle157.84 EUR
BB Lower149.37 EUR
BB Width10.73%
ATR (14)3.853 EUR
Vol Ratio (20d)0.80x